Replies to post #539 on Enanta Pharmaceuticals Inc (ENTA)

[willyw]

By the time we get Abbvie 3-D pricing we should also have some sense of the efficacy of the 2nd gen compounds; 493 and 530, and the shape of the FDA phase 2B trials. (we are told 2B trials start dosing this summer)

I look forward to hearing your sensibilities on that as well, if there is sufficient information.